Toward standardized brain tumor tissue processing protocols in neuro-oncology: a perspective for gliomas and beyond

Front Oncol. 2024 Sep 23:14:1471257. doi: 10.3389/fonc.2024.1471257. eCollection 2024.

Abstract

Implementation of standardized protocols in neurooncology during the surgical resection of brain tumors is needed to advance the clinical treatment paradigms that use tissue for diagnosis, prognosis, bio-banking, and treatment. Currently recommendations on intraoperative tissue procurement only exist for diffuse gliomas but management of other brain tumor subtypes can also benefit from these protocols. Fresh tissue from surgical resection can now be used for intraoperative diagnostics and functional precision medicine assays. A multidisciplinary neuro-oncology perspective is critical to develop the best avenues for practical standardization. This perspective from the multidisciplinary Oncology Tissue Advisory Board (OTAB) discusses current advances, future directions, and the imperative of adopting standardized protocols for diverse brain tumor entities. There is a growing need for consistent operating room practices to enhance patient care, streamline research efforts, and optimize outcomes.

Keywords: biobank; brain tumors; gliomas; precision medicine; tissue processing.

Grants and funding

The author(s) declare financial support was received for the research, authorship, and/or publication of this article. AR is funded by 1R03CA289645-01, P50MD017319-03 and the Robert A. Winn Diversity in Clinical Trials Award Program. TJ is funded by the NHS Foundation Trust. All research at Great Ormond Street Hospital NHS Foundation Trust and UCL Great Ormond Street Institute of Child Health is made possible by the NIHR Great Ormond Street Hospital Biomedical Research Centre. HB is funded by the NIH, Johns Hopkins University, Khatib Foundation, NICO Corporation, and philanthropy.